Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model
This study investigates the effects of methylene blue (MB) in a mouse model of Alzheimer’s disease (AD) induced by neuroinflammation. The study found that MB treatment reduced amyloid beta (Aβ) oligomers, decreased oxidative stress, and improved mitochondrial function by inhibiting the mitochondrial enzyme ABAD. Additionally, MB treatment restored brain estradiol